Prior to joining Verity Health, Adcock served as executive vice president and chief innovation officer for Sanford Health. In this role, he was responsible for leading Sanford Health's growth and innovation, in addition to direct operational oversight of related entities Sanford Research, Sanford Health Plan, Sanford Foundation, Sanford Frontiers, Profile by Sanford, and Sanford World Clinic.
He began his tenure at Sanford in 2004, serving in various positions including director, vice president and executive vice president for Sanford Clinic, and president of Sanford Frontiers.
Earlier, he was director of engineering and a Six Sigma Master Black Belt for GE Medical Systems. He began his career in the medical field as co-owner and vice president of research and development at Micro Medical Systems.
Verity Health System employs more than 6,000 staff statewide. The hospitals include 1,650 inpatient beds, six active emergency rooms, a trauma center, and a host of medical specialties including tertiary and quaternary care.
Verity's two Southern California hospitals are St. Francis Medical Center in Lynwood and St. Vincent Medical Center in Los Angeles. In Northern California, O'Connor Hospital in San Jose, St. Louise Regional Hospital in Gilroy, Seton Medical Center in Daly City, and Seton Coastside in Moss Beach are part of Verity Health.
Verity Health also includes Verity Physician Network and Verity Medical Foundation, encompassing hundreds of physicians across a variety of practice models, independent practice associations, ambulatory surgery centers and urgent care centers.
Since its creation in December 2015, Verity Health System has worked to revitalize its hospitals in Northern and Southern California and ensure financial sustainability in order to care for patients for generations to come including the underserved.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business